# KaloCyte, Inc. — Form D

KaloCyte, Inc. of ST. LOUIS, MO, a company, filed a Form D exempt-offering notice with the SEC on 2018-05-08. The offering totals $800K, of which $800K was reported sold. Industry: Biotechnology.

## Offering

- Filed: 2018-05-08
- Form: D
- Accession: 0001738542-18-000001
- Industry: Biotechnology
- Exemptions: 06b
- Total offering: $800K
- Amount sold: $800K
- Minimum investment: $10K
- Investors: 3
- Date of first sale: 2018-04-27
- Security types: equity
- Revenue range: $1 - $1,000,000
- SEC file number: 021-311892

## Issuer

- Name: KaloCyte, Inc.
- CIK: 0001738542
- Entity type: Corporation
- Jurisdiction: MISSOURI
- Incorporated: 2016
- Address: 4320 FOREST PARK, ST. LOUIS, MO, 63108
- Phone: 3148099819

## Officers, directors & promoters (6)

| Name | Role | Location |
| --- | --- | --- |
| Allan Doctor | Director | Saint Louis, MO |
| Daniel Getman | Director | Kirksville, MO |
| Gregory Lanza | Director | Saint Louis, MO |
| Dipanjan Pan | Director | State College, PA |
| Philip Spinella | Director | Chesterfield, MO |
| Allan Doctor | Executive Officer | Saint Louis, MO |

## More

- [CIK 1738542 on SEC EDGAR (source of record)](https://www.sec.gov/cgi-bin/browse-edgar?action=getcompany&CIK=1738542&type=&dateb=&owner=include&count=40)
- [This page as markdown (for LLM agents)](https://search.stillhousedata.com/formd/0001738542-18-000001.md)
- [Search all SEC filings, advisers and people on Adviser Search](https://search.stillhousedata.com/)

---

Source: public SEC filing data via Adviser Search (https://search.stillhousedata.com).
Agents: this data is also queryable via MCP tools and read-only SQL — see https://search.stillhousedata.com/llms.txt.